Dr Reddy’s Shares Slide After Chinese Regulator Suspends Atomoxetine Hydrochloride Capsule
Dr Reddy’s Laboratories saw its shares dip after the National Medical Products Administration of China (NMPA) suspended the import, sale, and use of the company’s Atomoxetine Hydrochloride capsules. By 10:30 AM, the pharma giant’s stock had fallen 1.4 percent to Rs 6,937 on the NSE. The suspension follows a remote inspection conducted by NMPA at […]